InTextoResearch, agence d'information scientifique
InTextoResearch vous informe sur les dernières parutions d'articles de
revue sur le cancer du pancreas (20 novembre 2007):
Role of platinum agents in the management of advanced pancreatic
cancer.
Saif MW, Kim R.
Expert Opin Pharmacother. 2007 Nov;8(16):2719-27.
Pancreatic adenocarcinoma: diagnosis and staging using multidetector-
row computed tomography (MDCT) and magnetic resonance imaging (MRI).
Francis IR.
Cancer Imaging. 2007 Oct 1;7 Spec No A:S160-5.
Controversies in the adjuvant treatment of pancreatic adenocarcinoma.
Saif MW.
JOP. 2007 Sep 7;8(5):545-52.
Advances in counselling and surveillance of patients at risk for
pancreatic cancer.
Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban
RH, Brentnall TA, Lynch HT, Canto MI; Participants of the Fourth
International Symposium of Inherited Diseases of the Pancreas.
Gut. 2007 Oct;56(10):1460-9.
International consensus guidelines for the management of IPMN and MCN
of the pancreas.
Tanaka M.
Nippon Shokakibyo Gakkai Zasshi. 2007 Sep;104(9):1338-43.
Surgery insight: surgical management of pancreatic cancer.
Michalski CW, Weitz J, Büchler MW.
Nat Clin Pract Oncol. 2007 Sep;4(9):526-35.
Is it relevant that intra-arterial chemotherapy may be effective for
advanced pancreatic cancer?
Ishikawa T.
World J Gastroenterol. 2007 Aug 28;13(32):4306-9.
Autoimmune pancreatitis.
Toomey DP, Swan N, Torreggiani W, Conlon KC.
Br J Surg. 2007 Sep;94(9):1067-74.
Risk of pancreatic cancer in patients with cystic fibrosis.
Maisonneuve P, Marshall BC, Lowenfels AB.
Gut. 2007 Sep;56(9):1327-8.
Ectopic hepatocellular carcinoma arising from pancreas: a case report
and review of the literature.
Kubota K, Kita J, Rokkaku K, Iwasaki Y, Sawada T, Imura J, Fujimori T.
World J Gastroenterol. 2007 Aug 21;13(31):4270-3.
Future strategies for targeted therapies and tailored patient
management in pancreatic cancer.
Ko AH.
Semin Oncol. 2007 Aug;34(4):354-64.
Cytotoxic therapy for advanced pancreatic adenocarcinoma.
O'Reilly EM, Abou-Alfa GK.
Semin Oncol. 2007 Aug;34(4):347-53.
Future chemoradiation strategies in pancreatic cancer.
Crane CH, Varadhachary G, Pisters PW, Evans DB, Wolff RA.
Semin Oncol. 2007 Aug;34(4):335-46.
Adjuvant therapy for pancreas cancer: advances and controversies.
Mulcahy MF.
Semin Oncol. 2007 Aug;34(4):321-6.
Guidelines for the surgical management of pancreatic adenocarcinoma.
Ujiki MB, Talamonti MS.
Semin Oncol. 2007 Aug;34(4):311-20.
Identifying molecular markers for the early detection of pancreatic
neoplasia.
Goggins M.
Semin Oncol. 2007 Aug;34(4):303-10.
Strategies for screening for pancreatic adenocarcinoma in high-risk
patients.
Canto MI.
Semin Oncol. 2007 Aug;34(4):295-302.
Detecting early pancreatic cancer: problems and prospects.
Chari ST.
Semin Oncol. 2007 Aug;34(4):284-94.
Mechanisms of disease: chronic inflammation and cancer in the
pancreas--a potential role for pancreatic stellate cells?
Algül H, Treiber M, Lesina M, Schmid RM.
Nat Clin Pract Gastroenterol Hepatol. 2007 Aug;4(8):454-62.
Antiproteases in preventing the invasive potential of pancreatic
cancer cells.
Takahashi H, Sawai H, Funahashi H, Matsuo Y, Yasuda A, Ochi N, Sato M,
Okada Y, Takeyama H.
JOP. 2007 Jul 9;8(4 Suppl):501-8.
Magnetic resonance imaging in the detection of pancreatic neoplasms.
Zhong L.
J Dig Dis. 2007 Aug;8(3):128-32.
Pancreatic cancer: is this bleak landscape finally changing?
Highlights from the '43rd ASCO Annual Meeting'. Chicago, IL, USA. June
1-5, 2007.
Saif MW.
JOP. 2007 Jul 9;8(4):365-73.
(contact pour InTextoResearch: Marc Lacroix, Baelen, Wallonie,
Belgique - scimedweb@mail.com)